153 related articles for article (PubMed ID: 24932229)
41. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
[TBL] [Abstract][Full Text] [Related]
42.
Li ZN; Zhao L; Yu LF; Wei MJ
Gastroenterol Rep (Oxf); 2020 Jun; 8(3):192-205. PubMed ID: 32665851
[TBL] [Abstract][Full Text] [Related]
43. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A
Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771
[TBL] [Abstract][Full Text] [Related]
44. Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis.
Ottaiano A; Normanno N; Facchini S; Cassata A; Nappi A; Romano C; Silvestro L; De Stefano A; Rachiglio AM; Roma C; Maiello MR; Scala S; Delrio P; Tatangelo F; Di Mauro A; Botti G; Avallone A; Nasti G
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708575
[TBL] [Abstract][Full Text] [Related]
45. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
46. Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing.
Armengol G; Sarhadi VK; Ghanbari R; Doghaei-Moghaddam M; Ansari R; Sotoudeh M; Puolakkainen P; Kokkola A; Malekzadeh R; Knuutila S
J Mol Diagn; 2016 Jul; 18(4):471-9. PubMed ID: 27155048
[TBL] [Abstract][Full Text] [Related]
47. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
[TBL] [Abstract][Full Text] [Related]
48. Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.
Ulivi P; Capelli L; Valgiusti M; Zoli W; Scarpi E; Chiadini E; Rosetti P; Bravaccini S; Calistri D; Saragoni L; Casadei Gardini A; Ragazzini A; Frassineti GL; Amadori D; Passardi A
J Transl Med; 2012 May; 10():87. PubMed ID: 22569004
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer.
Phua LC; Ng HW; Yeo AH; Chen E; Lo MS; Cheah PY; Chan EC; Koh PK; Ho HK
Oncol Lett; 2015 Oct; 10(4):2519-2526. PubMed ID: 26622882
[TBL] [Abstract][Full Text] [Related]
50. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.
Bersani C; Sivars L; Haeggblom L; DiLorenzo S; Mints M; Ährlund-Richter A; Tertipis N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Oncotarget; 2017 May; 8(21):35339-35350. PubMed ID: 28525363
[TBL] [Abstract][Full Text] [Related]
51. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis.
Nunes L; Aasebø K; Mathot L; Ljungström V; Edqvist PH; Sundström M; Dragomir A; Pfeiffer P; Ameur A; Ponten F; Mezheyeuski A; Sorbye H; Sjöblom T; Glimelius B
Acta Oncol; 2020 Apr; 59(4):417-426. PubMed ID: 31924107
[No Abstract] [Full Text] [Related]
53. Clinical Impact of PI3K/BRAF Mutations in RAS Wild Metastatic Colorectal Cancer: Meta-analysis Results.
Mohamed A; Twardy B; AbdAllah N; Akhras A; Ismail H; Zordok M; Schrapp K; Attumi T; Tesfaye A; El-Rayes B
J Gastrointest Cancer; 2019 Jun; 50(2):269-275. PubMed ID: 29388061
[TBL] [Abstract][Full Text] [Related]
54. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
[TBL] [Abstract][Full Text] [Related]
55. Integrating
Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
[TBL] [Abstract][Full Text] [Related]
57. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
Schechter RB; Nagilla M; Joseph L; Reddy P; Khattri A; Watson S; Locati LD; Licitra L; Greco A; Pelosi G; Carcangiu ML; Lingen MW; Seiwert TY; Cohen EE
Cancer Lett; 2015 Apr; 359(2):269-74. PubMed ID: 25641339
[TBL] [Abstract][Full Text] [Related]
58. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
[TBL] [Abstract][Full Text] [Related]
59. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
60. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.
Maeng CH; Lee J; van Hummelen P; Park SH; Palescandolo E; Jang J; Park HY; Kang SY; MacConaill L; Kim KM; Shim YM
PLoS One; 2012; 7(8):e41655. PubMed ID: 22870241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
